National Comprehensive Cancer Network, Pfizer Award Grants for Rare Cancer Patient Care Improvement

The National Comprehensive Cancer Network Oncology Research Program, in collaboration with Pfizer Independent Grants for Learning & Change, has awarded six independent grants to healthcare institutions to improve patient care and outcomes for those suffering from rare cancers.

Advertisement

The grants were awarded following a joint Request for Proposals focused on the development and adoption of evidence-based initiatives to improve care for renal cell carcinoma and hematologic malignancies.

The organizations receiving the grant are:

•    Fred and Pamela Buffett Cancer Center at The University of Nebraska Medical Center in Omaha
•    Duke Cancer Institute in Durham, N.C.
•    East Carolina University in Greenville, N.C.
•    Fox Chase Cancer Center in Philadelphia
•    Minneapolis-based National Marrow Donor Program
•    Aurora-based University of Colorado Cancer Center

More Articles on Quality:

Despite Guidelines, Antibiotics Prescribed at High Rate for Bronchitis
New Pathogen-Identification Method Leads to Cost Savings: Study
Kaiser South Sacramento Patients Potentially Exposed to Whooping Cough

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.